Peter DeNardis, who works in Planning & Analysis in the Office of the Chief Financial Officer, has been appointed chair of the board of trustees of the International Waldenstrom’s Macroglobulinemia Foundation — an organization devoted to education, patient support and research of a rare form of lymphoma.
DeNardis, who was diagnosed with the disease in 2003, will become chair of the international nonprofit cancer organization on Dec. 1.
“When first diagnosed in 2003, I immediately turned to the internet to find out about my rare cancer with the strange name,” he said in a news release from the organization. “Fortunately, it didn't take long to find the IWMF, and the resource it provides for WM patients and caregivers.
“With each relapse and unusual health issue, the IWMF community has been there for me and my family to guide us and provide comfort and support. Like many others around the world, we've been able to take advantage of the ever-expanding services and information provided under the guidance of the IWMF Board Chairs, Board members, and staff. I consider myself fortunate to have the opportunity to give back to the IWMF and carry the torch to light the way for other WMers facing life with WM.”